SCHEMBL14872199

SCHEMBL14872199

O=C(COc1ccc(Cl)cc1Cl)Oc1cccc2cccnc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
GAA P10253 2/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
THRB P10828 1/20 0.53
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
HPGD P15428 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
MITF O75030 1/20 0.50
TP53 P04637 1/20 0.50
PKM P14618 1/20 0.50
XBP1 P17861 1/20 0.50
MAPT P10636 5/20 0.49
ALDH1A1 P00352 3/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16022757 0.88 LMNA (0.55) LMNASMN1; SMN2GAAL3MBTL1NPC1
SCHEMBL28380448 0.81 TDP1 (0.54) SMN1; SMN2GAAL3MBTL1NPC1RAB9A
SCHEMBL22504147 0.81 LMNA (0.61) LMNASMN1; SMN2GAAL3MBTL1NPC1
SCHEMBL27375098 0.81 TDP1 (0.59) LMNASMN1; SMN2GAAL3MBTL1THRB
SCHEMBL14872195 0.78 NPC1 (0.61) LMNASMN1; SMN2GAAL3MBTL1THRB
SCHEMBL4457246 0.76 LMNA (0.66) LMNASMN1; SMN2GAAL3MBTL1NPC1
SCHEMBL27374907 0.76 TDP1 (0.52) LMNASMN1; SMN2GAAL3MBTL1THRB
SCHEMBL27374991 0.76 HPGD (0.62) LMNASMN1; SMN2GAAL3MBTL1THRB
SCHEMBL27522659 0.75 TDP1 (0.64) SMN1; SMN2GAAL3MBTL1THRBHPGD
SCHEMBL27828214 0.75 LMNA (0.57) LMNASMN1; SMN2GAAL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11465960-B2 Labile esters of agrochemicals for controlled release and reduction of off-site movement MONSANTO TECHNOLOGY LLC (US) 2022-10-11 US disclosed
US-20200392063-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT MONSANTO TECHNOLOGY LLC (US) 2020-12-17 US disclosed
US-20170029355-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT MONSANTO TECHNOLOGY LLC 2017-02-02 US disclosed
US-20170029355-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT MONSANTO TECHNOLOGY LLC 2017-02-02 US disclosed
US-20140256549-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT MONSANTO TECHNOLOGY LLC (US) 2014-09-11 US disclosed
WO-2013055944-A2 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT MONSANTO TECHNOLOGY LLC (US) 2013-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11465960-B2 Labile esters of agrochemicals for controlled release and reduction of off-site movement APEH, GUSB, CES2 LMNA 2263/4885SMN1; SMN2 3744/4885GAA 12/4885
US-20200392063-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT APEH, GUSB, CES2 LMNA 2263/4885SMN1; SMN2 3744/4885GAA 12/4885
US-20170029355-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT APEH, GUSB, CES2 LMNA 2263/4885SMN1; SMN2 3744/4885GAA 12/4885
US-20140256549-A1 LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT APEH, GUSB, CES2 LMNA 2263/4885SMN1; SMN2 3744/4885GAA 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.